Recombinant growth factor

This page covers all Recombinant growth factor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Nerve growth factor receptor (TrkA, p75NTR), TGF-β3 (Transforming Growth Factor Beta-3).

Targets

Nerve growth factor receptor (TrkA, p75NTR) · TGF-β3 (Transforming Growth Factor Beta-3)

Marketed (1)

• OXERVATE® 0.002% · Dompé Farmaceutici S.p.A · Ophthalmology
  OXERVATE contains recombinant human nerve growth factor (rhNGF) that promotes corneal nerve regeneration and healing of neurotrophic keratopathy.

Phase 3 pipeline (1)

• Juvista (Avotermin) · Renovo · Dermatology / Wound Healing
  Avotermin is a recombinant human transforming growth factor beta-3 (TGF-β3) that modulates wound healing to reduce scarring.